blasts under 5 percent of bone marrow nucleated cells

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Total-Body Irradiation
  • +8 more
  • Los Angeles, California
  • +9 more
Aug 19, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in Aurora,

Completed
  • Acute Biphenotypic Leukemia
  • +6 more
  • Aurora, Colorado
  • +2 more
Jan 12, 2022

Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

Terminated
  • Acute Myeloid Leukemia
  • +4 more
  • Aldesleukin
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 15, 2021

Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Chronic Lymphocytic Leukemia Trial in

Completed
  • Aggressive Non-Hodgkin Lymphoma
  • +20 more
  • Atorvastatin Calcium
  • +7 more
  • Denver, Colorado
  • +1 more
Dec 26, 2019